A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes
Clinical trial NCT06649344 · COMPLETED
Trial details
- NCT number
- NCT06649344
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2026-07-18
- Enrollment
- 884
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.